Lael Cragin

Estimating Costs of Care for Patients with Newly Diagnosed Metastatic Colorectal Cancer

L. Clark Paramore, Simu K. Thomas, Kevin Knopf et al. · Clinical Colorectal Cancer · 2006 · 52 citations

Pharmacy, Oncology, Pharmacoeconomics +12

Adverse Event Burden, Resource Use, and Costs Associated with Immunosuppressant Medications for the Treatment of Systemic Lupus Erythematosus: A Systematic Literature Review

Alan Oglesby, A. Shaul, Tiffany Pokora et al. · International Journal of Rheumatology · 2013 · 34 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Comparison of the metabolic and economic consequences of long‐term treatment of schizophrenia using ziprasidone, olanzapine, quetiapine and risperidone in Canada: a cost‐effectiveness analysis

Roger S. McIntyre, Lael Cragin, Sonja Sorensen et al. · Journal of Evaluation in Clinical Practice · 2010 · 29 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Cost-effectiveness of empagliflozin versus canagliflozin, dapagliflozin, or standard of care in patients with type 2 diabetes and established cardiovascular disease

Odette S. Reifsnider, Pranav Gandhi, Lael Cragin et al. · BMJ Open Diabetes Research & Care · 2021 · 27 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Cost-effectiveness of a Fourth-Generation Combination Immunoassay for Human Immunodeficiency Virus (HIV) Antibody and p24 Antigen for the Detection of HIV Infections in the United States

Lael Cragin, Feng Pan, Siyang Peng et al. · HIV Clinical Trials · 2012 · 17 citations · Full text

Public Health, Infectious Diseases, Pharmacoeconomics +17